China Releases First Supplement to 2020 Pharmacopoeia with 47 New Drug Varieties
The National Medical Products Administration (NMPA) and the National Health Commission have announced the release...
NMPA
NMPA and NHC Tighten Regulations on Etomidate and Modafinil
The National Medical Products Administration (NMPA) and the National Health Commission (NHC) have jointly issued...
Hunchun Port Designated as Medical Materials Import Port by NMPA and GAC
The National Medical Products Administration (NMPA) and the General Administration of Customs have jointly released...
CDE Introduces New Guidelines for Generic Drug Quality and Efficacy Consistency Evaluation
The Center for Drug Evaluation (CDE) has released a new set of Guidelines for “the...
NMPA Seeks Comments on Medical Device Classification Draft Proposal
The National Medical Products Administration (NMPA) has issued a notification focusing on the definition and...
Chongqing Lummy Pharmaceutical’s Subsidiary Receives NMPA Approval for CUD002 mRNA Vaccine
Chongqing Lummy Pharmaceutical Co., Ltd (SHE: 300006), through its subsidiary Sichuan Cunde Therapeutics Co., Ltd,...
CDE Annual Report: Clinical Trials for Innovative Drugs in China Reach Record High
The Center for Drug Evaluation (CDE) has released its annual report on clinical trials in...
NMPA Drafts Guidelines for Supervising Online Drug Exchange Platforms
The National Medical Products Administration (NMPA) has released draft “Online Third-party Drug Exchange Platforms Inspection...
Taizhou Port Designated as Drug Import Port by NMPA and General Administration of Customs
The National Medical Products Administration (NMPA) and the General Administration of Customs have released a...
Li Li Appointed as New Director of NMPA
The State Council has released an announcement regarding appointments and dismissals within the government. Among...
NMPA Revises Drug Conditional Approval Procedures: Streamlined Processes and Requirements
The National Medical Products Administration (NMPA) has released the “Drug Conditional Approval Filing Review and...
China Releases Third List of Pediatric Drugs to Guide Development and Filings
The National Health Commission (NHC), National Healthcare Security Administration, National Medical Products Administration (NMPA), and...
NMPA Releases 72nd Batch of Reference Drugs for GQCE
The National Medical Products Administration (NMPA) has released the 72nd batch of reference drugs for...
National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector
An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July...
NMPA Seeks Public Input on Strengthening Supervision of Medical Device Contract Manufacturing
The National Medical Products Administration (NMPA) is currently seeking public feedback on the “Opinions on...
NMPA Updates List of Medical Devices Exempt from Clinical Evaluation in China
The National Medical Products Administration (NMPA) has released an updated version of the “List of...
National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector
The emergency response department of the National Health Commission (NHC) has released a notification signaling...
NMPA Releases 70th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 70th batch of reference drugs for...
Shanghai Fosun Pharmaceutical Submits Tenapanor Approval Application to China’s NMPA
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196), a China-based pharmaceutical company, has announced a...
Kedrion Biopharma Achieves First Product Approval in China for Human Albumin
Italy-headquartered blood products specialist Kedrion Biopharma has announced that its subsidiary, Bio Products Laboratory (BPL),...